Press release
Co-Chairs from Aerie Pharmaceuticals & Santen Inc USA Invite Industry Experts to join Ophthalmic Drugs
The conference will explore advancements in ophthalmic treatments and variety of novel drugs, which are showing great clinical trial data. There will also be a specific focus on drug delivery along with advancements in novel technologies. Further key areas will be gene therapy and Artificial Intelligence with developments on the latest drug pipelines and clinical trials.
The conference is co-chaired by Mitchell A. (Mitch) de Long who holds the position of vice president, Chemistry at Aerie Pharmaceuticals as well as Adjunct Professor of Chemistry at Duke University. Since Mitch helped to found Aerie as a Duke University spinout in 2005, Aerie has filed 5 INDs and 2 NDAs, with its first FDA approval coming in 2017 and
Najam (Naj) Sharif, PhD, DSc (Southampton University, UK) has >34-years' pharmaceutical drug discovery research/development experience covering neuroscience and ophthalmology. He is Currently the Vice President of Global Alliances and External Research, Ophthalmology Innovation Center at Santen Inc USA.
The co-chairs Mitchell de Long and Naj Sharif invitation letter to join the conference mentions:
"The Ophthalmic Drugs conference will bring together expertise from individuals in multiple disciplines of the field. Our packed agenda will offer a series of presentations, through which you will gain insight into new industry developments and clinical trials, innovations in the treatment of rare diseases, regulatory perspectives, and advances in gene therapy"
"As the Co-chairs of this conference, we look forward to personally welcoming you to this must-attend conference in London this November."
The full invitation chair letter can be found in the brochure at www.ophthalmicdrugs.com/pr4openpr
Key benefits of attending, incude
• Assess new industry directions through the latest data from ophthalmic clinical trials
• Review advanced techniques in treating age-related diseases of ophthalmology
• Explore evolving therapeutic potential in undruggable diseases through innovative gene therapies
• Examine novel methodologies in delivery technologies being used to further the ophthalmic therapeutic field
• Engage in the regulatory landscape of ophthalmic drugs and key considerations for R&D
The Ophthalmic Drugs Conference is proudly sponsored by Celanese, Ora, Inc., TTP Plc.
For sponsorship enquiries contact Andrew Gibbons, Project Manager in +44 (0) 20 7827 6156 or andrew.gibbons@saemediagroup.com
For media partnerships and press enquiries contact Simi Sapal, Head of Marketing on +44 (0)827 or email simi.sapal@saemediagroup.com
Ophthalmic Drugs
21-22 November 2022
London, UK
www.ophthalmicdrugs.com/pr4openpr
#OphthalmicDrugs
Ophthalmic Drugs
21-22 November 2022
London, UK
www.ophthalmicdrugs.com/pr4openpr
#OphthalmicDrugs
About SAE Media Group Conferences:
SAE Media Group Conferences connects global communities with focused networking conferences. We provide our customers with solutions through industry knowledge and collaboration that enables our attendees to return to their organisations better equipped to overcome their key business challenges. Our key events focus on Defence and Aerospace, Pharmaceutical and Medical. Each year we bring together over 5,000 senior business professionals at our conferences. http://www.smgconferences.com
SAE Media Group (SMG), a subsidiary of SAE International, reports the latest technology breakthroughs and design innovations to a global audience of nearly 1,000,000 engineers, researchers, and business managers. SMG provides critical information these professionals need to develop new and improved products and services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Co-Chairs from Aerie Pharmaceuticals & Santen Inc USA Invite Industry Experts to join Ophthalmic Drugs here
News-ID: 2779949 • Views: …
More Releases from SAE Media Group
Launch of the C-UAS Hub Report 2025: Countering the Threat: A Comprehensive Revi …
SAE Media Group, renowned for its sell-out Counter UAS Conferences and owner of the C-UAS Hub, is excited to announce the release of its first-ever C-UAS Hub Report 2025, titled "Countering the Threat: A Comprehensive Review of National C-UAS Programs."
As drones continue to play an increasingly prominent role in both military and civilian sectors, the demand for effective Counter UAS solutions is growing rapidly. NATO allies are making significant investments…
How MilSatCom has transformed warfare and continues to shape the battlefield.
The advancement of space-based communications technologies, including the ever-increasing presence of military satellites for electronic and signals intelligence purposes, has dramatically changed the way wars are fought down on Earth.
From the launch of the first satellite communications network to the cutting-edge technology that is still in development, below we take a look at how far MilSatCom has come.
A brief history of MilSatCom
The first military communications satellites were launched by the…
Conference Co-chairs from Merck & AstraZeneca invitation to join 3D Cell Culture
SAE Media Group reports: Conference co-chairs invite delegates to join the anticipated 6th Annual 3D Cell Culture Conference
SAE Media Group is delighted to announce the return of successful 3D Cell Culture Conference for its 6th year, taking place on 8 and 9 February 2023 in London, UK.
The 2023 Conference theme is on exploring the implementation of complex in-vitro models for drug development
Visit the website at http://www.3d-cellculture.com/PR2 to find out…
Exploring the Implementation of Complex In-vitro Models for Drug Development
SAE Media Group reports: Agenda and speaker overview released for the 6th Annual 3D Cell Culture Conference, London, UK
SAE Media Group is delighted to announce the return of successful 3D Cell Culture Conference for its 6th year, taking place on 8 and 9 February 2023 in London, UK.
3D Cell Culture has gained increasing momentum in the pharmaceutical industry over recent years, with the global 3D Cell Culture market predicted to…
More Releases for Ophthalmic
Prominent Ophthalmic Knives Market Trend for 2025: Innovative Developments In Op …
Which drivers are expected to have the greatest impact on the over the ophthalmic knives market's growth?
The increasing prevalence of eye-related conditions is expected to boost the ophthalmic knives market. Conditions such as cataracts, glaucoma, and diabetic retinopathy are rising due to aging populations and lifestyle changes. Ophthalmic knives are used in surgeries to treat these conditions, helping to improve vision and manage eye health. The CDC's January 2024 report…
Ophthalmic Devices Market
According to the report, the global ophthalmic devices market garnered $32.53 billion in 2019, and is estimated to reach $44.86 billion by 2027, registering a CAGR of 4.0% from 2020 to 2027.
Drivers, restraints, and opportunities-
Increase in adoption of digital devices in health care sector and technological advancement in the ophthalmic devices drive the growth of the global ophthalmic devices market. However, lack of sled professional and low awareness regarding eye-related…
Ophthalmic Femtosecond Lasers Market Size, Rising Trends to 2033 Lensar, Ziemer …
Ophthalmic femtosecond lasers are ultra-fast lasers operating at femtosecond (10⁻¹⁵ seconds) pulse durations, enabling precise and minimally invasive eye surgeries. Unlike traditional lasers, they use photodisruption to create tissue incisions without generating heat, significantly reducing collateral damage. These lasers are pivotal in procedures such as LASIK flap creation, cataract surgery (lens fragmentation), and corneal transplants, allowing for unparalleled precision and customization. Advanced features like high-frequency pulse rates and real-time optical…
Ophthalmic Packaging Market Report 2024 - Ophthalmic Packaging Market Trends And …
"The Business Research Company recently released a comprehensive report on the Global Ophthalmic Packaging Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample…
Ophthalmic Lasers Market - Empowering Progress, Shaping Eye Care Excellence: Rev …
Newark, New Castle, USA - new report, titled Ophthalmic Lasers Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Ophthalmic Lasers market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Ophthalmic Lasers market. The report offers an overview of the market, which…
Ophthalmic Trial Frames Market Depth Survey Report 2019| Topcon, Luneau, Takagi …
Ophthalmic trial frames are adjustable frames that are used to hold lenses during refraction test and during retinoscopy test of the eye. Ophthalmic trial frames are eyeglasses designed in such a way that different lenses can be inserted and can be used to correct refractive errors of vision. Ophthalmic trial frames are light weight, adjustable and should have a comfortable nose resting and can be adjusted to allow accurate centering.…
